Glaxo Grp Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLAXO GRP LTD, and when can generic versions of GLAXO GRP LTD drugs launch?
GLAXO GRP LTD has eight approved drugs.
There are eight US patents protecting GLAXO GRP LTD drugs.
There are two hundred and thirteen patent family members on GLAXO GRP LTD drugs in thirty-two countries and thirty supplementary protection certificates in sixteen countries.
Drugs and US Patents for Glaxo Grp Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxo Grp Ltd | ADVAIR DISKUS 500/50 | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 021077-003 | Aug 24, 2000 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Glaxo Grp Ltd | ZANTAC 300 | ranitidine hydrochloride | TABLET;ORAL | 018703-002 | Dec 9, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Glaxo Grp Ltd | ZANTAC 150 | ranitidine hydrochloride | TABLET;ORAL | 018703-001 | Jun 9, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Glaxo Grp Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxo Grp Ltd | FLOVENT HFA | fluticasone propionate | AEROSOL, METERED;INHALATION | 021433-002 | May 14, 2004 | 9,861,771 | ⤷ Sign Up |
Glaxo Grp Ltd | ADVAIR HFA | fluticasone propionate; salmeterol xinafoate | AEROSOL, METERED;INHALATION | 021254-002 | Jun 8, 2006 | 7,350,676*PED | ⤷ Sign Up |
Glaxo Grp Ltd | ZANTAC 300 | ranitidine hydrochloride | TABLET;ORAL | 018703-002 | Dec 9, 1985 | 4,128,658 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for GLAXO GRP LTD drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 150 mg | ➤ Subscribe | 2007-10-30 |
International Patents for Glaxo Grp Ltd Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Denmark | 1467789 | ⤷ Sign Up |
Cyprus | 1122241 | ⤷ Sign Up |
China | 101084030 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Glaxo Grp Ltd Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1425001 | C20140013 00103 | Estonia | ⤷ Sign Up | PRODUCT NAME: VILANTEROOLTRIFENATAAT;REG NO/DATE: K(2013)8089 (LOPLIK) 13.11.2013 |
1425001 | 92439 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: VILANTEROL OU UN SEL OU UN SOLVATE DE CELUI-CI |
1425001 | CA 2014 00021 | Denmark | ⤷ Sign Up | PRODUCT NAME: VILANTEROL ELLER ET SALT ELLER SOLVAT DERAF, HERUNDER VILANTEROL TRIFENATAT; REG. NO/DATE: EU/1/13/886/001-006 20131113 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.